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562Objective: The bidirectional Glenn procedure is a well-established procedure performed as part of the single-ven-
tricle palliation pathway. Numerous studies have highlighted the potential benefits of an ‘‘early’’ BDG procedure.
The ideal age to perform the BDG procedure, however, remains uncertain. We report our experience with the
BDG procedure in patients younger than 3 months.
Methods: One hundred sixty-nine consecutive patients from 1998 to 2007 undergoing the BDG procedure were
divided into 2 groups: younger than 3 months (n¼ 20) and older than 3 months. The groups were compared for 26
variables. All data were analyzed with Kaplan–Meier survival analysis and the Cox proportional hazard regres-
sion test to assess the probability of survival after the BDG procedure in both groups. A stepwise regression anal-
ysis was performed for identification of independent factors for postoperative oxygen saturation at hospital
discharge.
Results: The groups were comparable, with an equal distribution of patients with right-sided or left-sided single-
ventricle anatomy. Although intensive care unit length of stay, ventilation time, and hospital length of stay were
longer in the younger group, room air oxygen saturations at discharge, both early and late mortality, and time to
the Fontan procedure were similar between groups. The independent variables found for death after the BDG pro-
cedure were preoperative mean pulmonary artery pressure, atrioventricular valve regurgitation, and postoperative
oxygen saturations at hospital discharge. Survival in patients with hypoplastic left heart syndrome was compa-
rable between groups after 5 years of follow-up.
Conclusion: The BDG procedure is feasible and safe in patients as young as 2 months of age, with early and late
mortality equivalent to that seen in older patients. (J Thorac Cardiovasc Surg 2010;139:562-8)The bidirectional cavopulmonary shunt (bidirectional Glenn
procedure [BDG]) is a well-established procedure per-
formed as part of the single-ventricle pathway that culmi-
nates in the Fontan procedure.1 There have been numerous
studies looking at the timing of the BDG procedure, with
many highlighting the potential benefits of performing an
‘‘early’’ BDG procedure. These include removing a volume
load from the single ventricle that can benefit atrioventricu-
lar (AV) valve insufficiency and perhaps improve long-term
diastolic function, decreasing the effective cardiac output
required from the single ventricle, avoiding potential pul-
monary tree distortions seen with systemic to pulmonary
shunts, and perhaps preventing the development of pulmo-
nary vascular obstructive disease from the same.2 Despite in-
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The Journal of Thoracic and Cardiovascular Surgprocedure,3,4 there is continued controversy regarding the
timing, with some arguing little benefit in waiting beyond
4 months4 and others cautioning against performing the pro-
cedure in those younger than 3 months.5 These cautions
stem from concern with possibly increased mortality and
morbidity with an early BDG procedure, the possibility
that the pulmonary arteries will not be as well developed
with passive flow, and the potential adverse effects on
cerebral circulation or long-term candidacy for Fontan
completion.
Although some prior reports, mainly from the 1990s, doc-
ument poor outcomes,6,7 more recently, others have shown
good outcomes in younger patients after the BDG proce-
dure.4,8,9 Nevertheless, the ideal age and age limits to per-
form the BDG procedure remain uncertain. The purpose of
this report is to show our experience with the BDG proce-
dure in patients younger than 3 months and to identify which
predictive variables either impede or enhance progress to the
Fontan procedure.MATERIALS AND METHODS
Data Collection
After institutional review board approval, a retrospective review of data
was carried out in a cohort of patients who had undergone the BDG proce-
dure from 1998 to 2007 at our institution. Patient files were analyzed for de-
mographic, echocardiographic, and catheterization data. Patients who hadery c March 2010
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DAbbreviations and Acronyms
AV ¼ atrioventricular
BDG ¼ bidirectional Glenn procedure
BT ¼ Blalock–Taussig
HLHS ¼ hypoplastic left heart syndrome
ICU ¼ intensive care unitbeen lost to follow-up, patients with incomplete data, or both were excluded
from the study.
Patients undergoing the BDG procedure were divided into 2 groups
based on age at the time of the operation: patients less than 3 months of
age (younger group) were compared with patients who were older than 3
months (older group). The older group was referred for the BDG procedure
solely at the discretion of the referring cardiologists and typically for wors-
ening cyanosis. The younger group, in contrast, could be categorized into
one of 2 groups. One was a nonpalliated group who presented because of
cyanosis (with or without heart failure), and the initial step of (usually) Bla-
lock–Taussig (BT) shunt was skipped in favor of an early BDG procedure.
The other category included patients with hypoplastic left heart syndrome
(HLHS) after first-stage palliation who were pushed toward an early BDG
procedure in the hopes of unloading their ventricles, with resultant improve-
ment in their clinical status.
Preoperative records and follow-up data were reviewed. Detailed clinical
diagnoses with comorbidities, duration of hospital stay, duration of inten-
sive care unit (ICU) stay, and time from admission to surgical intervention
were recorded. The duration of ventilation time and preoperative and post-
operative room air oxygen saturations at hospital discharge were also noted.
The preoperative echocardiographic information, such as right and left pul-
monary branch sizes andAV valve regurgitation, were recorded. AV valve re-
gurgitation was graded as severe, moderate, mild, or absent based on pulse
wave tracing and color Doppler mapping. Data from cardiac catheterizations
performed before the BDG procedure were reviewed. Systemic oxygen satu-
rations on roomair, indexedpulmonary and systemic cardiac output ratio, ven-
tricular end-diastolic pressure, mean pulmonary artery pressure, and indexed
pulmonary vascular resistance were noted from catheterization records. Be-
cause of difficulties attributable to vascular access or clinically based deci-
sions, not all patients were catheterized nor were catheterization data
variables available for all patients (n¼ 17). The time between catheterization
and the BDG procedure was variable but generally no longer than 3 weeks.
Surgical details noted included cardiopulmonary bypass time; proce-
dures done before the BDG procedure, such as the Norwood procedure, pul-
monary artery banding, or a prior BT shunt; and simultaneous procedures
done at the time of the BDG procedure, such as pulmonary artery band tight-
ening and atrial septectomy. In addition, a note was made of the presence or
absence of antegrade pulmonary blood flow before and after the BDG pro-
cedure. We defined antegrade flow as any flow through the native main pul-
monary artery and pulmonary valve only; patients who received a right
ventricle to pulmonary artery conduit (eg, Sanomodification) as part of their
initial palliation were not included under this definition. For all patients, the
anastomosis was constructed in an end-to-side fashion after division of the
superior vena cava and oversewing of the cardiac end of the vessel. In most
patients the BDG procedure was performed with cardiopulmonary bypass
support, whereas in some the procedure was carried out off-pump, typically
if there was antegrade blood flow from the ventricle to the main pulmonary
artery. Crossclamp time reflects the ischemic time that was incurred in those
patients requiring additional procedures at the time of the BDG procedure
(eg, creation of an atrial septal defect). A bilateral cavopulmonary anasto-
mosis was constructed in the presence of bilateral superior vena cavae. Sur-
gical techniques were not different between the younger and older groups.
For anticoagulation, heparin was used in the immediate postoperative period
and then replaced with aspiring after removal of intracardiac lines. It wasThe Journal of Thoracic and Carecorded on late follow-up whether Fontan procedure was completed and,
if so, the time interval to the Fontan completion. Early surgical mortality
was defined as mortality before hospital discharge or at 30 days, whichever
was latest, according to the Society of Thoracic Surgeons guidelines. Long-
term mortality was any mortality beyond the early period.
Statistical Analysis
All data were expressed as medians, means  standard deviations, or
both. Twenty-seven variables (collected from both groups before, at the
time of, and after the BDG procedure) were analyzed and compared be-
tween the 2 groups (Table 1). For time variables, the numbers of postoper-
ative days were noted (eg, from postoperative day 0 to 1 is considered 1
day). Comparisons between the 2 groups was made by using the c2 test
for categorical variables, variance-stabilizing transformations being per-
formed as appropriate. Mean values for variables (collected from both
groups before, at the time of, or after the BDG procedure) were compared
between the 2 groups by using the t test or Wilcoxon rank sum test as appro-
priate. Kaplan–Meier survival and stepwise Cox proportional hazards re-
gressions analyses were performed to assess survival after the BDG
procedure in both groups. The Cox model was adjusted for room air post-
operative oxygen saturations at discharge, preoperative mean pulmonary
artery pressure, age at the time of the BDG procedure, the presence of ante-
grade pulmonary blood flow before the BDG procedure, and preoperative
calculated pulmonary vascular resistance.
A stepwise regression analysis was performed to identify independent
factors for postoperative oxygen saturation at hospital discharge. Indepen-
dent variables were included in the model if the P value was less than .05.
RESULTS
During the study period, 183 patients underwent the BDG
procedure. Fourteen patients (all>3 months of age at the
time of the BDG procedure) were excluded because of miss-
ing data or because of loss to follow-up. There were 20 pa-
tients younger than 3 months of age (younger group) and
149 patients older than 3 months of age (older group). De-
mographics, age at the time of the BDG procedure, associ-
ated procedures, length of hospital stay, duration of
mechanical ventilation, length of ICU stay, and primary di-
agnoses are summarized in Table 2. At the time of the BDG
procedure, the youngest patient was 55 days old, and the old-
est patient was 660 days old.
The younger group showed fewer prior operations than the
older group (50.00% vs 85.23%, P¼ .0041). In the younger
group the prior operations were as follows: 1 patient under-
went pulmonary artery banding with simultaneous coarcta-
tion repair, 2 patients underwent the BT shunt procedure,
and 7 patients underwent first-stage HLHS palliation, one
of whom never left the hospital until the BDG procedure.
All preoperative hemodynamic data are summarized in
Table 3. The echocardiographic data are also summarized
in Table 3. Branch pulmonary arteries were of similar size
between groups, as well as the degree of AV valve regurgi-
tation for every classification: absent, mild, and moderate.
The late outcome after the BDG procedure was similar in
both groups (Table 4). There were no patients in the younger
group requiring heart transplantation, whereas in the older
group there were 4 patients requiring heart transplantation,
but this difference was not statistically significant (P¼ .97).rdiovascular Surgery c Volume 139, Number 3 563
TABLE 1. Variables analyzed
Variables before
BDG procedure
Variables at time of
BDG procedure
Variables after
BDG procedure
Right pulmonary
artery size
Body surface area ICU length stay
Left pulmonary artery
size
Concomitant
procedures at time
of BDG procedure
Mechanical
ventilatory support
time
Atrioventricular valve
regurgitation
Presence of
comorbidities
Time to follow-up
Oxygen saturation Cardiopulmonary
bypass time
Time to Fontan
completion
Prior surgical
procedure(s)
Crossclamp time Oxygen saturation at
hospital discharge
End-diastolic
ventricular pressure
Duration of chest tube
drainage
Mean pulmonary
pressure
Presence of antegrade
flow
Pulmonary vascular
resistance
Surgical mortality
Pulmonary/systemic
cardiac output ratio
Admittance hospital
time before BDG
procedure
Presence of left
superior vena cava
BDG, Bidirectional Glenn; ICU, intensive care unit.
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room air) were positively associated with previous antegrade
flow (P ¼ .0021) and negatively associated with preopera-
TABLE 2. Demographics, hospital data summary, and primary diagnoses
Older
(n ¼
Age at BDG procedure (d) 191.4 
Weight (kg) 6.13 
BSA (m2) 0.32 
Follow-up (y) 4.47 
Time to Fontan procedure (mo) 39.63 
Time from hospital admittance to BDG procedure (d) 1.00 
Duration of chest tube drainage (d) 2.1 
Hospital length of stay (d) 11.88 
Mechanical ventilation duration (d) 3.81 
ICU length of stay (d) 7.43 
Operative mortality 2 (1.
Prior operations 127 (85
Simultaneous procedures 21 (12
Crossclamp time 27.82 
Pump time (min) 98.49 
BDG procedure performed off bypass 29 (19
HLHS 51 (34
PA–IVS 16 (10
Tricuspid atresia 25 (16
Single ventricle 57 (38
BDG, Bidirectional Glenn; BSA, body surface area; ICU, intensive care unit; HLHS, hypop
*Median values.
564 The Journal of Thoracic and Cardiovascular Surgtive end-diastolic ventricular pressure (P ¼ .0357). Age at
the time of the BDG procedure was not associated with
worse postoperative oxygen saturations at discharge.
The effect of several risk factors on survival of the entire
cohort was assessed with stepwise Cox regression modeling.
The hazard ratio for preoperative pulmonary artery pressure
was 1.27 (95% confidence interval, 1.10–1.48; P ¼ .0014)
for each 1 mm Hg increment increase, and for postoperative
oxygen saturations at hospital discharge, it was 0.81 (95%
confidence interval, 0.71–0.94; P ¼ .0039) for each 1% of
oxygen saturation increment increase. Age at the time of
the BDG procedure was not an independent variable for
death and did not enter into the regression model. The AV
valve regurgitation before the BDG procedure was associ-
ated with survival based on univariate analysis.
The evaluation of 2 survival curves showed a survival
probability of 94.7%  5.12% in the younger group and
95.7% 1.73% in the older group, with no statistical differ-
ence (P ¼ .82; Figure 1, A).
In the HLHS subgroup late survival in both groups was
comparable (80.0%  17.9% vs 87.4%  6.50%,
P¼ .31), with 1 death in the younger group and 4 in the older
group (Figure 1, B). In the sameHLHS subgrouping, postop-
erative oxygen saturations at discharge were slightly lower
in the younger group when compared with those in the older
group but with no statistical significance (77.00% 3.46%
vs 81.00%  4.86%, P ¼ .08).
Analyzing all patients (HLHS and non-HLHS diagnosis),
the postoperative oxygen saturations at hospital discharge
for patients with HLHS were lower when compared withgroup
149)
Younger group
(n ¼ 20) P value
7.19 83.15  3.21 <.0001
0.11 4.83  0.19 <.0001
0.01 0.27  0.01 <.0001
3.23 3.31  2.75 .1625
1.32 39.23  4.72 .9249
26.67 3.00  23.05 .0143
1.1 (2.0)* 2.8  2.28 (2.0)* .5742
2.51 (6.0)* 24.55  6.74 (10.5)* <.0001
23.10 (1.0)* 8.50  22.78 (2.0) * .0198
28.20 (3.0)* 13.30  25.14 (4.0)* .0048
34%) 1 (5.0%) .7823
.23%) 10 (50.00%) .0041
.42%) 3 (15.00%) .7365
17.92 22.00  19.67 .6408
40.40 106.92  47.33 .5459
.46%) 7 (35.00%) .1739
.2%) 5 (25.0%) .6420
.7%) 2 (10.0%) .8045
.8%) 3 (15.0%) .4736
.3%) 10 (50.0%) .9325
lastic left heart syndrome; PA–IVS, pulmonary atresia with intact ventricular septum.
ery c March 2010
TABLE 3. Perioperative hemodynamic status and echocardiographic data
Older group
(n ¼ 149)
Younger group
(n ¼ 20) P value
Qp:Qs flow ratio 1.3  0.1 1.2  0.3 .45
End-diastolic ventricular pressure (mm Hg) 6.8  0.2 7.1  0.64 .68
Pulmonary mean pressure (mm Hg) 13.6  0.4 13.2  1.5 .73
Pulmonary vascular resistance (WU/m2) 2.7  0.1 1.9  0.2 .4937
Preoperative oxygen saturation (%) 77  0 72  3 .0122
Postoperative oxygen saturation at discharge (%) 83  0 82  1 .4764
Left pulmonary size (cm) 0.51  0.04 0.42  0.03 .4311
Right pulmonary size (cm) 0.52  0.03 0.47  0.03 .5643
Atrioventricular valve regurgitation Absent: 49% Absent: 60.0% .4929
Mild: 40.9% Mild: 30.0% .4987
Moderate: 10.1% Moderate: 10.0% .7029
Antegrade flow before BDG procedure Yes: 57 (33.7%) Yes: 14 70.0% 0.0127
No: 112 (66.3%) No: 6 (30.0%)
Antegrade flow after BDG procedure Yes: 17 (10.06%) Yes: 5 (25.0%) .1891
No: 152 (90.0%) No: 15 (75.0%)
Presence of left superior vena cava Yes: 10.1% (15) Yes: 0.0% (0) .0633
Qp:Qs, Indexed pulmonary and systemic cardiac output ratio; BDG, bidirectional Glenn.
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5%, P ¼ .001).DISCUSSION
A number of prior reports have documented the feasibility
of performing an early BDG procedure.3-6,10,11 Table
52,3,4,10-12 summarizes data from prior reports and the cur-
rent study. Performance of the BDG procedure, currently
typically done before 6 months of age,2,3 was historically re-
ported to be associated with poorer outcomes in younger pa-
tients.6 Others had argued against performing the BDG
procedure in patients 2 months of age or younger.3
In our series we showed lowmortality among patients less
than 3 months of age, with approximately 35% of the youn-
ger cohort being only 2 months old. Our results are similar to
other recent reports of excellent outcomes after the BDG
procedure,4 which is perhaps a reflection of an era effect.
Our only death in the less than 3-month-old cohort was a pa-
tient with HLHS who underwent the Norwood procedure on
day 3 of life. This patient underwent mechanical ventilation
for his entire life, never left the hospital, and underwent the
BDG procedure with multiple comorbidities. Not surpris-TABLE 4. Late outcomes after the BDG procedure (excluding
operative mortality)
Older group
(n ¼ 147)
Younger group
(n ¼ 19) P value
Died 6 (4.1%) 0 (0.0%) .8046
Not candidate
for Fontan procedure
5 (3.4%) 0 (0.0%) .8995
Waiting for Fontan procedure 43 (29.3%) 9 (47.4%) .1046
Transplantation 4 (2.7%) 0 (0.0%) .9702
Fontan procedure 89 (60.5%) 10 (52.6%) .5685
The Journal of Thoracic and Caingly, this patient had a protracted ICU stay, ventilation
time, and hospital stay as well.
Intuitively, one might expect that the HLHS subset of pa-
tients would be perhaps at higher risk for poor outcomes.
When analyzing the subgroup of patients with HLHS versus
those with other diagnoses, however, we found similar out-
comes; again, age was not predictive of mortality risk. Fur-
thermore, both groups, younger and older than 3 months,
were comparable in terms of hemodynamic data, as well
as echocardiographic measurements. The main differences
between our groups were weight, body surface area, age,
hospital length of stay, ICU length of stay, mechanical ven-
tilation duration, time from admittance to the BDG proce-
dure, and number of prior operations. Weight, body
surface area, and age were not surprising considering the
group definitions. The younger group had a less smooth
postoperative course, as evidenced by longer hospital length
of stay, ICU length of stay, and mechanical ventilation dura-
tion, but this did not result in increased early or late mortal-
ity, which is consistent with prior reports.13,14 We make
a concerted effort to wean patients off any supplemental
oxygen before hospital discharge, which could have resulted
in longer hospital length of stay for the younger group.
Whether the increased ICU (median of 4 vs 3 days for the
younger vs older groups) or ventilation time is of clinical
significance is questionable. In addition, the increased ven-
tilation time and ICU and hospital length of stay and associ-
ated costs have to be contrasted versus the substantially
fewer prior operations the younger group had relative to
the older group (ie, skipping 1 prior palliative procedure).
In the younger group 10 patients had prior operations. In
this subgroup 7 had first-stage palliation for HLHS, and
only 1 remained in the hospital until the BDG procedure.
The remaining 10 younger patients underwent semielectiverdiovascular Surgery c Volume 139, Number 3 565
FIGURE 1. A, actuarial curve for death after the bidirectional Glenn (BDG) procedure in the younger and older groups. B, actuarial curve for death for
patients with hypoplastic left heart syndrome (HLHS) in the younger and older groups. C, Scatter plot of age distribution of patients at the time of the
BDG procedure. The x-axis is age at the time of the BDG procedure in days. A line demarcates the separation of the older and younger group at 3 months
of age.
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TABLE 5. Summarized data from prior reports and the current study
Author Year
No. of
patients
Average age
at BDG
procedure
(mo)
Hospital
mortality
(30 d)
Present report 2008 20 2.8 5.0%
Jaquiss and coworkers4 2004 33 3.1 0.0%
Bradley and coworkers11 1996 85 4.8 5.9%
Slavik and coworkers10 1996 4 1.3 0.0%
Reddy and coworkers3 1997 42 3.7 4.8%
Reddy and coworkers2 1995 9 2.6 0.0%
Chang and coworkers12 1993 17 6.5 6.0%
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a BT shunt.
We observed that the younger group had longer hospital
admittance periods before the BDG procedure, which is
likely reflective of the surprise presentation of these children
with either newly discovered congenital heart disease and
cyanosis or sudden deterioration of the clinical status after
prior palliative procedures.
Previous reports had suggested that performance of
a BDG procedure in patients less than 6months of age would
result in lower oxygen saturations.10,11 A more recent report
by Jaquiss and colleagues4 also showed that patients who
underwent the BDG procedure at an age of less than 4
months had lower postoperative saturations and longer
ICU and hospital stays. In the preceding study all patients
had undergone the Norwood procedure, and more than
60% had a primary diagnosis of HLHS.4 Overall, however,
the oxygen saturation difference between the groups was
small (75% vs 81%) and showed minimal clinical signifi-
cance. In contrast, we found that the post-BDG oxygen sat-
urations at hospital discharge were comparable between the
groups, and certainly none of the younger patients was dis-
charged on supplemental oxygen. Our study, however, in-
cludes not only patients with HLHS, as in Jaquiss and
colleagues’ study,4 but also patients with other single-ventri-
cle anatomy. Consistent with Jaquiss and colleagues’ report,
we also showed that patients with HLHS overall also had
lower oxygen saturations when compared with other patients
with single-ventricle physiology. Therefore it appears that
the primary diagnosis might have greater influence on post-
operative saturations than age at the time of the BDG proce-
dure.
The presence of antegrade pulmonary blood flow after the
BDG procedure has been a controversial subject.15 Ante-
grade flow has been demonstrated both to improve and com-
plicate the immediate postoperative and interstage clinical
course after the BDG procedure.16,17 Advantages of ante-
grade native pulmonary flow include promotion of normal
pulmonary artery growth and maintenance of pulmonary ar-
tery endothelial function.16,18 We showed an improvement
in postoperative oxygen saturation after the BDG procedureThe Journal of Thoracic and Cain patients who previously had antegrade flow (ie, before the
BDG procedure). The presence of antegrade flow before the
BDG procedure was not associated with death or poor out-
come after the BDG procedure in our series. Because we
had only 22 patients with antegrade pulmonary blood flow
after the BDG procedure (17 in the older group and 5 in
the younger group), we did not find any influence of ante-
grade flow after the BDG procedure on stepwise regression
analysis. Calvaruso and associates,19 in a recent article,
showed improvement in survival and oxygen saturations,
with maintenance of antegrade flow after the BDG proce-
dure. Kogon and coworkers11 recently also showed that out-
comes were unaffected by the presence of antegrade
pulmonary blood flow after the BDG procedure, comple-
menting our findings. Therefore antegrade pulmonary blood
flow does not preclude progression and completion of the
Fontan procedure and might indeed be a positive influence,
particularly in terms of reducing the risk of arteriovenous
malformations.
It is difficult to say how early the BDG procedure can be
safely performed, but based on our study results, we believe
that performing the BDG procedure at 2 months of age is
feasible and safe. Ghanayem and colleagues,9 with
a home-based monitoring system after the Norwood proce-
dure, showed an overall improvement in survival rates asso-
ciated with shortening of time to second-stage palliation.
The patients with home-based monitoring systems pro-
ceeded to the second stage at a mean age of 4.2 months com-
pared with patients not monitored at home, who proceeded
to the second stage at a mean age of 5.6 months. Indeed,
one of the strongest benefits of an early BDG procedure is
the potential decrease in interstage attrition, which was re-
ported by Ghanayem and colleagues in the range of 10%
to 15%.
Because age did not appear to affect mortality in our
study, we carried out further analysis of variables that
might affect outcomes after the BDG procedure for the
overall population of patients. This analysis led to identifi-
cation of 3 variables as having an influence on mortality
after the BDG procedure consistent with prior re-
ports2,13,18,20: mean pulmonary artery pressure, AV valve
regurgitation, and postoperative oxygen saturations at dis-
charge. Bridges and associates21 have shown that older pa-
tients are prone to higher pulmonary artery pressures and
are more cyanotic after the BDG procedure, which is sup-
portive of the importance of not delaying the BDG proce-
dure for too long. As in prior reports,3,13,21 the adverse
effects of AV regurgitation in our study are likely reflec-
tive of decreased effective cardiac output and increased
cardiac workload. A number of factors might contribute
to the regurgitation, including prolonged volume overload
from systemic to pulmonary shunts. This situation causes
an increase in myocardial mass and ventricular cavity en-
largement.22 Observation of structural myocyte changes inrdiovascular Surgery c Volume 139, Number 3 567
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cardiac collagen and elastin observed in experimental
models related to arteriovenous shunts24 again argue that
early intervention toward a more efficient flow circuit
(ie, the BDG procedure) would be beneficial.
Our study has several limitations, including all limitations
related to a retrospective study from a single institution. Fur-
thermore, the small number of patients in the younger group
limits the statistical power of the study. Finally, having per-
formed a retrospective study, we cannot adequately answer
the question of why the patients in the younger group had
their BDG procedures early. As in any procedure, the indi-
cation for that procedure can have a significant effect on out-
comes. We suspect that earlier in our study the indication for
an early BDG procedure was mainly related to lower oxygen
saturations in patients with likely less than optimal hemody-
namics. More recently, we have been more aggressive about
‘‘elective’’ implementation of the BDG procedure in pa-
tients once they reach the age of 2 months. Whether the re-
sults will be different in the upcoming era because of this
change in philosophy has yet to be determined, but we sus-
pect that such an approach will result in data that are even
more favorable. Lastly, we did not evaluate whether cerebral
perfusion in these very young patients was affected. More
refined studies are necessary in the future to address this
question.
In conclusion, carrying out the BDG procedure in pa-
tients less than 3 months of age (as early as 2 months)
is safe, with favorable long-term results. The early conver-
sion of the pulmonary blood flow source from a systemic
to pulmonary artery shunt to a cavopulmonary anastomosis
has advantages when done as soon as possible. Li and as-
sociates25 have shown that after Norwood palliation, the
required indexed cardiac output is on the order of 4 L/
min. The same analysis after the BDG procedure revealed
a value closer to 3 L/min.26 Clearly, the BDG procedure is
a more efficient circulation than systemic to pulmonary ar-
tery shunting. It is for the preceding and other reasons
noted before that we believed that performance of the
BDG procedure as early as possible could lead to better
long-term outcomes.20References
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